Atlas Trials

Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation

Clinical trial NCT00066469 · COMPLETED

Trial details

NCT number
NCT00066469
Sponsor
Children's Oncology Group
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoproliferative Disorder
Start date
2004-04-01
Primary completion
2009-10-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.